The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Virus Evolution
; 8(veac080), 2022.
Article
in English
| CAB Abstracts | ID: covidwho-2051563
ABSTRACT
The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organization as Alpha. Originating in early autumn but discovered in December 2020, it spread rapidly and caused large waves of infections worldwide. The Alpha variant is notable for being defined by a long ancestral phylogenetic branch with an increased evolutionary rate, along which only two sequences have been sampled. Alpha genomes comprise a well-supported monophyletic clade within which the evolutionary rate is typical of SARS-CoV-2. The Alpha epidemic continued to grow despite the continued restrictions on social mixing across the UK and the imposition of new restrictions, in particular, the English national lockdown in November 2020. While these interventions succeeded in reducing the absolute number of cases, the impact of these non-pharmaceutical interventions was predominantly to drive the decline of the SARS-CoV-2 lineages that preceded Alpha. We investigate the only two sampled sequences that fall on the branch ancestral to Alpha. We find that one is likely to be a true intermediate sequence, providing information about the order of mutational events that led to Alpha. We explore alternate hypotheses that can explain how Alpha acquired a large number of mutations yet remained largely unobserved in a region of high genomic surveillance an under-sampled geographical location, a non-human animal population, or a chronically infected individual. We conclude that the latter provides the best explanation of the observed behaviour and dynamics of the variant, although the individual need not be immunocompromised, as persistently infected immunocompetent hosts also display a higher within-host rate of evolution. Finally, we compare the ancestral branches and mutation profiles of other VOCs and find that Delta appears to be an outlier both in terms of the genomic locations of its defining mutations and a lack of the rapid evolutionary rate on its ancestral branch. As new variants, such as Omicron, continue to evolve (potentially through similar mechanisms), it remains important to investigate the origins of other variants to identify ways to potentially disrupt their evolution and emergence.
Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Molecular Biology and Molecular Genetics [ZZ360]; Genetics and Molecular Biology of Microorganisms [ZZ395]; Taxonomy and Evolution [ZZ380]; coronavirus disease 2019; epidemics; evolution; genome analysis; genomes; human diseases; immune competence; mutants; mutations; viral diseases; man; Severe acute respiratory syndrome coronavirus 2; UK; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; British Isles; Western Europe; Europe; Commonwealth of Nations; high income countries; OECD Countries; very high Human Development Index countries; SARS-CoV-2 variants; immunocompetence; immunological competence; SARS-CoV-2; Britain; United Kingdom; viral infections
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Topics:
Variants
Language:
English
Journal:
Virus Evolution
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS